In this Section |
243423 Trauma exposure among drug-endangered childrenSunday, October 30, 2011
Children have the best chance of developing normally when they live in healthy, predictable, and safe homes with parents who protect and adequately care for them. When they are exposed to stressful and traumatic events over long periods of time, the cumulative effects can create severe barriers to normal development. If not addressed, these stressors are likely to generate negative and serious health and mental health consequences for children. This study examines the differences in trauma exposure and the response to those events between drug endangered children and non-drug endangered children involved in the child welfare system. This data represents the experiences of 1127 children randomly selected from the state's child protective service database and represents 20% of all open cases during 2005-2006. Archival data was analyzed to determine the presence of exposure using DSM-IV-TR PTSD Criteria A1, and whether or not the child's response to exposure met PTSD Criteria A2. Results reveal high rates of trauma exposure in the DEC group and indicate that trauma exposure and trauma response did significantly vary across groups. Implications for the assessment and treatment of child welfare involved children are drawn.
Learning Areas:
Assessment of individual and community needs for health educationOther professions or practice related to public health Social and behavioral sciences Learning Objectives: Keywords: Child Abuse, Substance Abuse
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I amth Principal Investigator on this study and am the Buckhorn Professor of Child Welfare and Children's Mental Health at the University of Kentucky, and as such, conduct research and provide clinical services to address these issues. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Linking Public Health Practice to Family Violence
See more of: Family Violence Prevention Forum |